IGF2BP1 and astrocytoma (excluding glioblastoma): As shown in Supplementary figure 2A, in a single-cell RNA-seq analysis of astrocytoma dataset [75], 23 out of 28 m6A-RMRs (82%) (except ALKBH5, IGF2BP1, IGF2BP2, IGF2BP3, and G3BP2) were in the medium to high expression levels in malignant cells of astrocytoma.